Principal Financial Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
RCM
MG
Principal Financial Group's SANA Position: Q2 2026 in Review
Principal Financial Group opened a new position in Sana Biotechnology (SANA) in Q2 2026: 14,046 shares worth $49K. The stake represents ﹤0.01% of the portfolio and ranks #2134 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in SANA as recently as Q4 2024.
Principal Financial Group first reported a position in SANA in Q3 2021 and has held it in 15 quarters since. The position peaked at $571K in Q4 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.
- Principal Financial Group held 14,046 shares of Sana Biotechnology worth $49K as of Q2 2026.
- Sana Biotechnology was a new Principal Financial Group position in Q2 2026.
- Sana Biotechnology made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2134 holding.
- Principal Financial Group first reported a position in Sana Biotechnology in Q3 2021 and has held it in 15 quarters since.
- Principal Financial Group's Sana Biotechnology position peaked at $571K in Q4 2021.
- 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.